NCT00777114 2018-08-13
Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy
Weill Medical College of Cornell University
Phase 1 Completed
Clinical Trials
6 trialsNCT01536561 2017-08-31
Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma
GlaxoSmithKline
Phase 1 Completed
NCT00992758 2017-07-25
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement
GlaxoSmithKline
Phase 1 Completed
NCT00434629 2016-08-17
Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant
University of Pennsylvania
Phase 1 Completed
NCT00022880 2005-06-24
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
Corixa Corporation
Phase 1 Unknown
NCT00022906 2005-06-24
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement
Corixa Corporation
Phase 1 Unknown